Skip to main content

Closed

ABVX: Abivax S.A. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+133.5% / yr

Operating margin0.0%

ROIC-45.5%

Financially safe

Stretched

Debt / equity0.10×

Interest coverage-8.8×

Current ratio8.75×

Abivax S.A.

ABVXNASDAQ Global Market·USD·Closed

Abivax S.A.

ABVXNASDAQ·USD·Closed

$124.92

+0.47%

$124.92

+$0.59 (0.47%)

52W Range

71thpctl

Volume

0.59×avg

Mkt Cap

9.17BUSD

P/E

-22.0TTM

Div Yield

–ann

52W Range

71thpctl

Volume

0.59×avg

Market Cap

9.17BUSD

P/E Ratio

-22.0TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings